Edward B. Stinson | |
---|---|
Born | 1938 |
Nationality | American |
Education | Stanford University |
Known for |
|
Medical career | |
Profession | Cardiothoracic surgeon |
Field | Heart transplant |
Edward B. Stinson (born 1938) is an American retired cardiothoracic surgeon living in Los Altos, United States, who assisted Norman Shumway in America's first adult human-to-human heart transplantation on 6 January 1968 at Stanford University.
For over twenty years, Stinson was the principal investigator for the National Institutes of Health programme project in heart transplantation at Stanford.
In 1981, he was a founding member of the International Society for Heart and Lung Transplantation (ISHLT) and chaired their first international programme.
Edward Stinson was born in 1938 in San Diego, California [1] and graduated from Stanford University School of Medicine, [2] where he also completed his specialty training in cardiovascular surgery. [3] [4]
In 1965, three years prior to America's first adult human-to-human heart transplant, Stinson was part of the research team that published the classic paper which appraised experimental heart transplants at Stanford University Medical Center and demonstrated that the operative procedure could be successful. Of the just over 30 consecutive orthotopic transplants, most survived the operation until either rejection or immunosuppressant toxicity resulted in death. [5] Two particular adaptations in operative techniques were key to surviving the operation itself and were endorsed in the research. Atrial anastomosis was performed instead of joining the individual pulmonary veins and a teflon cuff wrapped around the aortic anastomosis was used as a seal to prevent a blood leak. [5]
The research provided the basis of knowledge for the world's first heart transplant by Christiaan Barnard and the later Stanford transplant programmes over the following decades when such programmes were shut down elsewhere. The importance of understanding the physiology of the cardiac homograft and the process of rejection was accepted as fundamental to understanding the best way to detect and treat rejection. [5] The issue of accurately detecting early rejection, of which Stinson was also involved, came later. [5] [6]
Stinson was Shumway's most notable resident [7] and the chief resident in 1968 [3] when he assisted Shumway in performing the first adult human-to-human heart transplant procedure in a 54-year-old steelworker, in the United States. [8] [9]
On 6 January 1968, he travelled to El Camino Hospital to bring the donor Virginia White to Stanford with her heart still beating. As soon as the neurologist confirmed White's brain death, surgery began in two adjacent operating theatres. After removing White's heart in room 12, Stinson carried it over in a cold saline filled bowl to Shumway in Room 13. [10]
Later, as professor emeritus of cardiothoracic surgery in 2006, he recalled;
After we removed the recipient’s heart, we stared at the empty pericardial cavity and wondered what we’d actually done.....We proceeded with implanting the new heart. It was pretty exciting to see it start up. [11]
Stinson stayed awake for most of the first five nights after surgery, monitoring recipient Kasperak, while the press continued to report on the whole event. [10]
Stinson joined the faculty in 1969. During 1970-72 he served as staff associate at the National Heart and Lung Institute Clinic of Surgery while on leave from Stanford. As staff associate, he was responsible for both clinical activity in cardiac surgery in the Clinic of Surgery of the National Heart Lung and Blood Institute and for intramural research programs addressing cardiac physiology and heart transplantation. [1] [12]
While training with Shumway, Stinson would perform almost exclusively cardiac surgery, with occasional assignments to general surgery. [13] Noted for his skill and speed at surgery, he was known as “Fast Eddie” in the operating theatre. [14]
In 1971, he reported with Shumway, Eugene Dong, D.A. Clark and R. B. Griepp, on the early heart transplants at Stanford. Later, in 1979, with Stuart W. Jamieson and Shumway, he reported on the later successes of heart transplants. [6] This report was one of the developments that helped the recommencement of heart surgery in the UK under Sir Terence English in 1979. [15]
On reflection of the worldwide transplants, Stinson stated
Many centers took up clinical transplantation without the laboratory experience or profound support in clinically related areas such as immunosuppression. They didn’t expect the difficulties that occurred after the operation. [16]
A heart transplant performed in 1970 by Stinson was later reported in the 1995 Guinness book of records when the recipient had survived more than twenty years. [17]
In 1972, Stinson and visiting Fellow Philip Caves, with the aim of detecting early organ rejection, performed the first heart biopsy after a heart transplant, [18] a procedure based on an adaptation of a Japanese bioptome. [6]
The following year, they authored the classic paper on transvenous endomyocardial biopsy, with Margaret Billingham and Shumway. [6] He was later described as "academically inspirational". [19]
In late 1980, he was part of the team that first introduced the anti-rejection drug cyclosporine for heart transplantation. [11]
Stinson led the donor team in the case of Andrew De La Pena in 1986 when a series of unexpected events caused a prolonged ischaemic time between heart removal from the donor and subsequent restoration of coronary circulation in the infant recipient (De La Pena). Despite this, the transplant was successful. [20]
In the week prior to Christmas of 1986 in Fargo, computer software matched a four-month-old infant donor with Stanford's five-month-old Andrew De La Pena, who had a rare heart defect. Stanford was more than 3 hours away from Fargo by flight and the maximum time a heart could remain outside the body before it ran out of oxygen, was considered around four hours. However, Stanford had the experience of more than 400 heart transplants by this time. The decision to bring the donor to Stanford was not possible as the donor liver was to go elsewhere. Both liver and heart teams were required to travel to Fargo and take back the donor organs to their corresponding recipients and shortly Stinson's team found themselves on a specially co-ordinated flight, complete with a “red igloo Playmate cooler” to Fargo's Hector International Airport. After a prolonged operation due to having to remove the liver, an aeroplane breakdown in North Dakota in extreme cold weather in the middle of the night resulted in further delay and prolonged graft anoxia. The whole time the donor heart was kept under strict low temperatures (hypothermia) in the cool box. Stinson was able to arrange from the Governor of North Dakota, George A. Sinner, an F-4 fighter jet (one of two stationed in the State) after surreptitiously being given his private telephone number. Further delays occurred attempting to fit the cooler in the jet. Subsequently, the donor heart was flown to Stanford on the two-seater fighter plane with the pilot only, that is without the donor team. The total anoxic time of the donor heart (Fargo to Stanford) was just short of eight hours, clearly missing the four-hour window. [20]
The story was published in the New York Times Magazine and then picked up by Reader's Digest and was published in a summarised article in February 1988 entitled "A New Heart for Andrew". [21] [22]
De La Pena survived Hodgkins Lymphoma and Hurricane Katrina. [22] 32 years later, in September 2018, he was reunited with the donor parents. [23]
In 1971, the National Institutes of Health awarded Stanford a National Institutes of Health programme project grant for further research, a venture which spanned more than twenty years. Stinson was its chief investigator. [24] [25] In addition, the American Heart Association awarded Stinson with an Established Investigatorship grant. [26] [27]
He became Director of the clinical heart transplant programme and Principal Investigator of the newly awarded programme project grant that provided essential support for clinical and research activities of the transplant programme, [4] [28] including subsequent combined heart and lung transplantation and then isolated lung transplantation. [29]
This core programmatic support from the NIH continued until 1993 by which time thoracic transplantation had become generally accepted by Medicare and the private insurance industry as standard therapy deserving of insurance coverage. [30] [31]
In addition to transplantation, Stinson was active in the entire spectrum of adult cardiac surgery and developed special interests in the surgical treatment of cardiac arrhythmias, infective endocarditis, and hypertrophic obstructive cardiomyopathy. Stinson continued as Director of the clinical heart transplant programme at Stanford until he retired and entered active emeritus status in 1998. [32]
By the year 2000, Stinson's directed Stanford's programme, supported by Shumway, had formed the foundations of expertise that led to 300 worldwide centres and 50,000 heart transplant procedures internationally. [29]
In 1981, Stinson was one of the founding members of the International Society for Heart and Lung Transplantation (ISHLT) along with other well known names in transplantation research including Michael Hess, Jack Copeland, Terence English, Stuart Jamieson, and Michael Kaye. The first official meeting and international programme took place on 14 March 1981 in San Francisco, California [33] with Stinson and Hess and chairmen. [34] He was also on its council between 1982 and 1984. [35]
Sir Magdi Habib Yacoub, is an Egyptian retired professor of cardiothoracic surgery at Imperial College London, best known for his early work in repairing heart valves with surgeon Donald Ross, adapting the Ross procedure, where the diseased aortic valve is replaced with the person's own pulmonary valve, devising the arterial switch operation (ASO) in transposition of the great arteries, and establishing the heart transplantation centre at Harefield Hospital in 1980 with a heart transplant for Derrick Morris, who at the time of his death was Europe's longest-surviving heart transplant recipient. Yacoub subsequently performed the UK's first combined heart and lung transplant in 1983.
Bruce A. Reitz is an American cardiothoracic surgeon, best known for leading the first combined heart-lung transplantation in 1981 with pioneer heart transplant surgeon Norman Shumway. He obtained an undergraduate degree at Stanford University a medical degree at Yale Medical School and completed an internship at Johns Hopkins Hospital (1971) and residencies and fellowships at Stanford University Hospital the National Institutes of Health (1974). He joined the surgical faculty at Stanford University (1978) then became chief of cardiac surgery at Johns Hopkins University (1982–92) and Chairman of the Department of Cardiothoracic Surgery at Stanford (1992–2005). In 1995 he conducted another pioneering operation: the first Heartport procedure, using a device that allows minimally invasive coronary bypass and valve operations. Reitz also played a major role in the resident education program at Stanford, which he reorganized and maintained.
Randall Bertram Griepp was an American cardiothoracic surgeon who collaborated with Norman Shumway in the development of the first successful heart transplant procedures in the U.S. He had an international reputation for contributions to the surgical treatment of aortic aneurysms and aortic dissection and in heart and lung transplantations. He received nearly $8 million in grants from the National Heart, Lung, and Blood Institute.
Norman Edward Shumway was a pioneer of heart surgery at Stanford University. He was the 67th president of the American Association for Thoracic Surgery and the first to perform an adult human to human heart transplantation in the United States.
A heart transplant, or a cardiac transplant, is a surgical transplant procedure performed on patients with end-stage heart failure or severe coronary artery disease when other medical or surgical treatments have failed. As of 2018, the most common procedure is to take a functioning heart, with or without both lungs, from a recently deceased organ donor and implant it into the patient. The patient's own heart is either removed and replaced with the donor heart or, much less commonly, the recipient's diseased heart is left in place to support the donor heart.
James K. Kirklin is an American cardiac surgeon who has made significant scientific and surgical contributions in the fields of heart transplantation and mechanical circulatory support devices to assist the pumping action of the heart. He was formerly Professor of Surgery (1987-2022), Director of the Division of Cardiothoracic Surgery (2006-2016), Director of the James and John Kirklin Institute for Research in Surgical Outcomes (2016–2022), and Co-Director of the University of Alabama at Birmingham (UAB) Comprehensive Cardiovascular Center (2011-2017). While at UAB, he held the UAB Cardiovascular Research Chair (1998-2006), the John Kirklin Chair of Cardiovascular Surgery (2006-2017), and the James Kirklin Chair of Cardiothoracic Surgery (2017-2022).
Sharon Ann Hunt is a cardiology professor and Director of the Post Heart Transplant Programme in Palo Alto, California and is affiliated with Stanford University Medical Center, professionally known for her work in the care of patients after heart transplantation.
Christian Emile Cabrol was a French cardiac surgeon best known for performing Europe's first heart transplant at Pitié-Salpêtrière Hospital in 1968.
Philip Caves (1940–1978) was an Irish cardiothoracic surgeon. In 1972, while at Stanford University, he pioneered the use of the bioptome and transvenous endomyocardial biopsy in the early diagnosis of heart transplant rejection. It was considered the most significant advance in antirejection therapy of the time. Awarded the British American Research Fellowship in 1971, Caves worked with pioneering cardiothoracic surgeon Norman Shumway at Stanford and became staff surgeon leading the transplant programme by 1973. A year later he went to Edinburgh as a senior lecturer in cardiac surgery, where he became particularly interested in pediatric cardiac surgery.
Margaret E. Billingham was a pathologist at Stanford University Medical Center, who made significant achievements in the early recognition and grading of transplant rejection following cardiac transplantation, known as 'Billingham's Criteria'. She also described chronic rejection and techniques in heart endomyocardial biopsy.
Prafulla Kumar Sen MD was an Indian vascular and cardiothoracic surgeon, who led the first human heart transplant procedure in India in 1968 and became the fourth surgeon in the world to carry out this operation. It was also the sixth attempt at this procedure in the world.
The International Society for Heart and Lung Transplantation (ISHLT), established in 1981, is a professional organization committed to research and education in heart and lung disease and transplantation. It holds annual scientific meetings and publishes The Journal of Heart and Lung Transplantation. It also holds the worlds largest registry of heart and lung transplant data.
Stuart William Jamieson is a British cardiothoracic surgeon, specialising in pulmonary thromboendarterectomy (PTE), a surgical procedure performed to remove organized clotted blood (thrombus) from pulmonary arteries in people with chronic thromboembolic pulmonary hypertension (CTEPH).
Jack Greene Copeland is an American cardiothoracic surgeon, who has established procedures in heart transplantation including repeat heart transplantation, the implantation of total artificial hearts (TAH) to bridge the time to heart transplant, innovations in left ventricular assist devices (LVAD) and the technique of "piggybacking" a second heart in a person, while leaving them the original.
Michael Peter Kaye was an American surgeon and researcher who co-founded the International Society for Heart and Lung Transplantation (ISHLT) in 1981. He developed the society's registry and edited the Journal of Heart and Lung Transplantation.
Michael L. Hess was an American professor of cardiology and physiology at the Medical College of Virginia (MCV) who was instrumental in founding the International Society for Heart and Lung Transplantation (ISHLT), of which he served as its first president.
Eric A. Rose is an American cardiothoracic surgeon, scientist, entrepreneur and professor and Chairman of the Department of Population Health Science & Policy, and Associate Director for Clinical Outcomes at Mount Sinai Heart. He is best known for performing the first successful paediatric heart transplant, in 1984 while at NewYork–Presbyterian Hospital (NYP).
Keith Reemtsma was an American transplant surgeon, best known for the cross-species kidney transplantation operation from chimpanzee to human in 1964. With only the early immunosuppressants and no long-term dialysis, the female recipient survived nine months, long enough to return to work.
Cardiac allograft vasculopathy (CAV) is a progressive type of coronary artery disease in people who have had a heart transplant. As the donor heart has lost its nerve supply there is typically no chest pain, and CAV is usually detected on routine testing. It may present with symptoms such as tiredness and breathlessness.
Mario Chih-Hsiung Karl Deng is a German-Chinese cardiologist specialized in the care of patients with advanced heart failure. Deng is a Professor of Medicine in the David Geffen School of Medicine at the University of California, Los Angeles.
{{cite book}}
: |first=
has generic name (help)